|
|
||||||||
APPETITE, OBESITY AND METABOLISM
1Department of Veterans Affairs Nebraska Western Iowa Health Care System, Omaha 68105; and Departments of 2Biomedical Sciences and 3Chemistry, Creighton University, Omaha, Nebraska 68178
Submitted 3 April 2003 ; accepted in final form 2 May 2003
Type A cholecystokinin receptor (CCKAR) antagonists differing in
blood-brain barrier permeability were used to test the hypothesis that satiety
is mediated, in part, by CCK action at CCKARs located peripheral to the
blood-brain barrier. At dark onset, non-food-deprived rats received a bolus
injection of devazepide (2.5 µmol/kg iv), a 3-h infusion of A-70104 (1 or 3
µmol·kg-1·h-1
iv), or vehicle either alone or coadministered with a 3-h infusion of CCK-8
(10 nmol·kg-1·h-1
iv) or a 2-h intragastric infusion of peptone (1 g/h). Food intake was
determined from continuous computer recordings of changes in food bowl weight.
Devazepide penetrates the blood-brain barrier; A-70104, the
dicyclohexylammonium salt of
N
-3-quinolinoyl-D-Glu-N,N-dipentylamide
(A-65186), does not. CCK-8 inhibited 3-h food intake by more than 50% and both
A-70104 and devazepide abolished this response. A-70104 and devazepide
stimulated food intake and similarly attenuated the anorexic response to
intragastric infusion of peptone. Thus endogenous CCK appears to act, in part,
at CCKARs peripheral to the blood-brain barrier to inhibit food intake.
receptor antagonist; devazepide; A-70104; satiety
This article has been cited by other articles:
![]() |
K. L. Whited, D. Thao, K. C. K. Lloyd, A. S. Kopin, and H. E. Raybould Targeted disruption of the murine CCK1 receptor gene reduces intestinal lipid-induced feedback inhibition of gastric function Am J Physiol Gastrointest Liver Physiol, July 1, 2006; 291(1): G156 - G162. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Sartor, A. Shulkes, and A. J. M. Verberne An enteric signal regulates putative gastrointestinal presympathetic vasomotor neurons in rats Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R625 - R633. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Cupples Physiological regulation of food intake Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2005; 288(6): R1438 - R1443. [Full Text] [PDF] |
||||
![]() |
R. Weikard, C. Kuhn, T. Goldammer, G. Freyer, and M. Schwerin The bovine PPARGC1A gene: molecular characterization and association of an SNP with variation of milk fat synthesis Physiol Genomics, March 21, 2005; 21(1): 1 - 13. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Reidelberger, J. Hernandez, B. Fritzsch, and M. Hulce Abdominal vagal mediation of the satiety effects of CCK in rats Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2004; 286(6): R1005 - R1012. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Burdyga, S. Lal, A. Varro, R. Dimaline, D. G. Thompson, and G. J. Dockray Expression of Cannabinoid CB1 Receptors by Vagal Afferent Neurons Is Inhibited by Cholecystokinin J. Neurosci., March 17, 2004; 24(11): 2708 - 2715. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |